TECH vs RVTY vs WAT vs BRKR

For growth investors, Waters Corporation (WAT) is the stronger pick with 7.

0% revenue growth year-over-year, versus 2. 1% for Bruker Corporation (BRKR). Waters Corporation (WAT) offers the better valuation at 32. 6x trailing P/E (24. 4x forward), making it the more compelling value choice. Analysts rate Bio-Techne Corporation (TECH) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Waters Corporation (WAT) is the cheapest at 32.

6x versus Bio-Techne Corporation at 110. 7x. On forward P/E, Revvity, Inc. is actually cheaper at 18. 3x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Waters Corporation (WAT) delivered a total return of +11.

3%, compared to -50. 3% for Bio-Techne Corporation (TECH). Over 10 years, the gap is even starker: WAT returned +162. 0% versus BRKR's +67. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Waters Corporation (WAT) is the lower-risk stock at 1.

07β versus Bruker Corporation's 1. 59β — meaning BRKR is approximately 48% more volatile than WAT relative to the S&P 500. On balance sheet safety, Bio-Techne Corporation (TECH) carries a lower debt/equity ratio of 23% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Waters Corporation (WAT) is pulling ahead at 7.

0% versus 2. 1% for Bruker Corporation (BRKR). On earnings-per-share growth, the picture is similar: Waters Corporation grew EPS 0. 5% year-over-year, compared to -119. 7% for Bruker Corporation. Over a 3-year CAGR, BRKR leads at 10. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Waters Corporation (WAT) is the more profitable company, earning 20.

3% net margin versus -0. 3% for Bruker Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus 6. 9% for BRKR. At the gross margin level — before operating expenses — TECH leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Revvity, Inc.

(RVTY) trades at 18. 3x forward P/E versus 25. 7x for Bio-Techne Corporation — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TECH: 36. 2% to $69. 33.

In this comparison, TECH (0.

6% yield), BRKR (0. 3% yield), RVTY (0. 3% yield) pay a dividend. WAT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Bio-Techne Corporation (TECH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0.

6% yield, +112. 5% 10Y return). Bruker Corporation (BRKR) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TECH: +112. 5%, BRKR: +67. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

TECH pays a dividend while RVTY, WAT, BRKR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.